drugset / Trial / NCT01017796
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
RandomizedParallel-groupSingle-blindPrevention
Summary
The use of N-acetylcysteine and ascorbic acid reduce the incidence of radiographic contrast agent induced reduction in renal function in Intensive Care Unit patients.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-01
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 1200 mg | Intravenous |
| Subject | Vitamin C | Other / unclassified | 1.5 g | Intravenous |